Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H9NO3.C4H11NO |
| Molecular Weight | 268.3089 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.CC(=O)NC1=CC=C(C=C1)C(O)=O
InChI
InChIKey=XTWZHJXJIIUEJP-UHFFFAOYSA-N
InChI=1S/C9H9NO3.C4H11NO/c1-6(11)10-8-4-2-7(3-5-8)9(12)13;1-5(2)3-4-6/h2-5H,1H3,(H,10,11)(H,12,13);6H,3-4H2,1-2H3
| Molecular Formula | C4H11NO |
| Molecular Weight | 89.1362 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C9H9NO3 |
| Molecular Weight | 179.1727 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DEANOL is an inactive component of CERAVE® hydrocortisone anti-itch cream, which is used for temporarily relieve itching associated with minor skin irritations, inflammation, and rashes due to eczema, soaps, detergents, cosmetics, seborrheic dermatitis, psoriasis. DEANOL is also used as a food additive.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % single, topical Highest studied dose Dose: 0.1 % Route: topical Route: single Dose: 0.1 % Sources: Page: p.10 |
healthy Health Status: healthy Sources: Page: p.10 |
|
6000 mg 1 times / day multiple, oral Highest studied dose Dose: 6000 mg, 1 times / day Route: oral Route: multiple Dose: 6000 mg, 1 times / day Sources: Page: p.188 |
unhealthy Health Status: unhealthy Condition: Involuntary movement disorders Sources: Page: p.188 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Improved method for the quality assurance of [C-11]choline. | 2002 Apr |
|
| Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. | 2002 Apr |
|
| Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. | 2002 Aug |
|
| Studies of the side chain cleavage of deramciclane in rats with radiolabelled compounds. | 2002 Mar |
|
| [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. | 2002 Sep |
|
| Reactivity and molecular recognition: amine methylation by an introverted ester. | 2003 Dec 3 |
|
| Water-soluble biodegradable cationic polyphosphazenes for gene delivery. | 2003 May 20 |
|
| The sea urchin embryo as a model for mammalian developmental neurotoxicity: ontogenesis of the high-affinity choline transporter and its role in cholinergic trophic activity. | 2003 Nov |
|
| Highly efficient automated synthesis of [(11)C]choline for multi dose utilization. | 2004 Jun |
|
| [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. | 2004 Jun 1 |
|
| Copper (II)-mediated arylation with aryl boronic acids for the N-derivatization of pyrazole libraries. | 2004 May-Jun |
|
| Synthesis of isostructural cage complexes of copper with cobalt and nickel for deposition of mixed ceramic oxide materials. | 2006 Dec 25 |
|
| A new design strategy for dispersion stabilization of Ni particles based on the surface acid and base properties of Ni particles. | 2007 Aug 15 |
|
| Self-assembly of the unique heterotrimetallic Cu/Co/M complexes possessing triangular antiferromagnetic {Cu2CoPb}2 and linear ferromagnetic {Cu2CoCd2} cores. | 2007 Feb 7 |
|
| Synthesis and characterization of succinylcholine-d18 and succinylmonocholine-d3 designed for simultaneous use as internal standards in mass spectrometric analyses. | 2007 Jul |
|
| The antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves a vacuolar cytopathology. | 2007 Mar |
|
| Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging. | 2007 May 1 |
|
| Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness. | 2007 Nov |
|
| Dimethylaminoethanol affects the viability of human cultured fibroblasts. | 2007 Nov-Dec |
|
| Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin. | 2007 Sep |
|
| Role of the ancillary ligand N,N-dimethylaminoethanol in the sensitization of Eu(III) and Tb(III) luminescence in dimeric beta-diketonates. | 2008 Apr 24 |
|
| Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer. | 2008 Feb |
|
| Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives. | 2008 Jun 26 |
|
| Experimental and theoretical investigation into the correlation between mass and ion mobility for choline and other ammonium cations in N2. | 2008 Mar 15 |
|
| Strong intramolecular Si-N interactions in the chlorosilanes Cl3-nHnSiOCH2CH2NMe2 (n = 1-3). | 2008 Nov 17 |
|
| Bis[N-(2-hydroxy-ethyl)-N-methyl-glycinato]copper(II). | 2008 Nov 22 |
|
| Quantitative determination of dimethylaminoethanol in cosmetic formulations by nuclear magnetic resonance spectroscopy. | 2008 Nov-Dec |
|
| Organocadmium aminoalcoholates: synthesis, structure, and materials chemistry. | 2008 Oct 20 |
|
| In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation. | 2009 Dec |
|
| Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. | 2009 Dec |
|
| Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesis. | 2009 Jul |
|
| The pentameric vertex proteins are necessary for the icosahedral carboxysome shell to function as a CO2 leakage barrier. | 2009 Oct 21 |
|
| Efficient automated one-step synthesis of 2-[18F]fluoroethylcholine for clinical imaging: optimized reaction conditions and improved quality controls of different synthetic approaches. | 2010 Apr |
|
| Application of high performance liquid chromatography coupled to on-line solid-phase extraction-nuclear magnetic resonance spectroscopy for the analysis of degradation products of V-class nerve agents and nitrogen mustard. | 2010 Apr 23 |
|
| First efficient synthesis of fluorinated glycidic esters from ketones. | 2010 Feb 19 |
|
| Mesotherapy - The french connection. | 2010 Jan |
|
| Structural characterization and stability of dimethylaminoethanol and dimethylaminoethanol bitartrate for possible use in cosmetic firming. | 2010 Jul-Aug |
|
| The choC gene encoding a putative phospholipid methyltransferase is essential for growth and development in Aspergillus nidulans. | 2010 Jun |
|
| Chloridotris[μ(2)-2-(dimethyl-amino)-ethano-lato]-μ(3)-hydroxido-tri-μ(2)-trifluoro-acetato-tetra-copper(II) tetra-hydro-furan solvate. | 2010 Jun 18 |
|
| In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. | 2010 Nov |
|
| Reduced dimethylaminoethanol in [(18)F]fluoromethylcholine: an important step towards enhanced tumour visualization. | 2010 Nov |
|
| Release of DNA from polyelectrolyte multilayers fabricated using 'charge-shifting' cationic polymers: tunable temporal control and sequential, multi-agent release. | 2010 Nov 20 |
|
| Novel pathway to synthesize unsymmetrical 2,3,9,10,16,17,23-heptakis(alkoxyl)-24-mono(dimethylaminoalkoxyl)phthalocyanines. | 2010 Oct 4 |
|
| Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds. | 2010 Sep 15 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:03:49 GMT 2023
by
admin
on
Fri Dec 15 15:03:49 GMT 2023
|
| Record UNII |
JSQ17GL1CN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
97399
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
3635-74-3
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
DTXSID60189880
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
22361
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
222-858-7
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
C004777
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
C76621
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
JSQ17GL1CN
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
SUB01558MIG
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
19265
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
100000084678
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | |||
|
m4115
Created by
admin on Fri Dec 15 15:03:49 GMT 2023 , Edited by admin on Fri Dec 15 15:03:49 GMT 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |